Broadline Capital

Broadline Capital, established in 2005 and headquartered in New York, is a private equity firm specializing in growth capital and impact investments, primarily in North America and Asia. The firm targets industries such as economic empowerment, sustainable energy, health, technology, and retail products, focusing on category leaders and innovators who are transforming their respective markets. Broadline Capital aims to leverage its extensive network and domain expertise to identify high-potential investment opportunities characterized by strong growth and profitability. Beyond providing financial support, the firm actively works with portfolio companies to enhance revenue growth, improve operations, and streamline processes. With a team composed of experienced entrepreneurs and former CEOs, Broadline Capital emphasizes building trust-based relationships and provides strategic guidance to help businesses realize their full potential. This approach ensures that the firm not only invests in promising companies but also contributes significantly to their development and success.

Chris Thorne

Executive Chairman

Victor Thorne

Managing Director and Co-Founder

8 past transactions

EndoSphere

Series C in 2016
EndoSphere is a developer of innovative, non-invasive devices aimed at treating gastrointestinal disorders and metabolic diseases, including obesity, non-alcoholic fatty liver disease, and type 2 diabetes. Founded in 2006 and headquartered in Columbus, Ohio, the company focuses on endoscopic therapies that leverage the body's natural physiology to facilitate safe and effective weight loss without the necessity for surgery or medication. By targeting obesity and its associated health conditions, EndoSphere's approach offers a promising alternative for patients seeking to improve their health outcomes through non-surgical means.

Powermers

Series B in 2016
Powermers Inc. specializes in the design and production of electro-conductive polymers aimed at enhancing the performance of energy storage devices, such as lithium-ion and lithium-air batteries, as well as super-capacitors. The company focuses on developing transition-metal based electro-conductive polymers that serve as efficient catalysts and electrochemical coating solutions for battery electrodes. Additionally, Powermers manufactures electro-conductive nanopolymer electrodes that self-assemble within carbon-based electrodes, significantly increasing their storage capacity. Founded in 2012 and headquartered in Westerville, Ohio, Powermers is recognized as an innovator in advanced materials, offering patented nano-scale catalytic polymers, coatings, and binders with diverse applications in energy storage technology.

China Rapid Finance

Series C in 2015
China Rapid Finance operates an online consumer lending marketplace focused on serving China's emerging middle class and providing access to consumer credit in a largely untapped market. The company aims to reach approximately 500 million economically active individuals who lack access to traditional bank credit, a market projected to exceed RMB 5.4 trillion by 2020. Utilizing advanced technology, including a proprietary Big Data analytics platform and an automated credit decision system, China Rapid Finance has transformed the consumer credit landscape in the country. With a strong emphasis on credit risk management and transparency, the company boasts over 5,000 employees and 80 data verification centers throughout China. Founded in 2001 by Dr. Zane Wang, a noted expert in consumer credit innovation, China Rapid Finance also plays a role in shaping industry standards, having advised the People's Bank of China on the development of national credit systems.

EndoSphere

Series B in 2012
EndoSphere is a developer of innovative, non-invasive devices aimed at treating gastrointestinal disorders and metabolic diseases, including obesity, non-alcoholic fatty liver disease, and type 2 diabetes. Founded in 2006 and headquartered in Columbus, Ohio, the company focuses on endoscopic therapies that leverage the body's natural physiology to facilitate safe and effective weight loss without the necessity for surgery or medication. By targeting obesity and its associated health conditions, EndoSphere's approach offers a promising alternative for patients seeking to improve their health outcomes through non-surgical means.

EndoSphere

Series A in 2011
EndoSphere is a developer of innovative, non-invasive devices aimed at treating gastrointestinal disorders and metabolic diseases, including obesity, non-alcoholic fatty liver disease, and type 2 diabetes. Founded in 2006 and headquartered in Columbus, Ohio, the company focuses on endoscopic therapies that leverage the body's natural physiology to facilitate safe and effective weight loss without the necessity for surgery or medication. By targeting obesity and its associated health conditions, EndoSphere's approach offers a promising alternative for patients seeking to improve their health outcomes through non-surgical means.

Powermers

Series A in 2011
Powermers Inc. specializes in the design and production of electro-conductive polymers aimed at enhancing the performance of energy storage devices, such as lithium-ion and lithium-air batteries, as well as super-capacitors. The company focuses on developing transition-metal based electro-conductive polymers that serve as efficient catalysts and electrochemical coating solutions for battery electrodes. Additionally, Powermers manufactures electro-conductive nanopolymer electrodes that self-assemble within carbon-based electrodes, significantly increasing their storage capacity. Founded in 2012 and headquartered in Westerville, Ohio, Powermers is recognized as an innovator in advanced materials, offering patented nano-scale catalytic polymers, coatings, and binders with diverse applications in energy storage technology.

China Rapid Finance

Series B in 2007
China Rapid Finance operates an online consumer lending marketplace focused on serving China's emerging middle class and providing access to consumer credit in a largely untapped market. The company aims to reach approximately 500 million economically active individuals who lack access to traditional bank credit, a market projected to exceed RMB 5.4 trillion by 2020. Utilizing advanced technology, including a proprietary Big Data analytics platform and an automated credit decision system, China Rapid Finance has transformed the consumer credit landscape in the country. With a strong emphasis on credit risk management and transparency, the company boasts over 5,000 employees and 80 data verification centers throughout China. Founded in 2001 by Dr. Zane Wang, a noted expert in consumer credit innovation, China Rapid Finance also plays a role in shaping industry standards, having advised the People's Bank of China on the development of national credit systems.

China Rapid Finance

Series A in 2005
China Rapid Finance operates an online consumer lending marketplace focused on serving China's emerging middle class and providing access to consumer credit in a largely untapped market. The company aims to reach approximately 500 million economically active individuals who lack access to traditional bank credit, a market projected to exceed RMB 5.4 trillion by 2020. Utilizing advanced technology, including a proprietary Big Data analytics platform and an automated credit decision system, China Rapid Finance has transformed the consumer credit landscape in the country. With a strong emphasis on credit risk management and transparency, the company boasts over 5,000 employees and 80 data verification centers throughout China. Founded in 2001 by Dr. Zane Wang, a noted expert in consumer credit innovation, China Rapid Finance also plays a role in shaping industry standards, having advised the People's Bank of China on the development of national credit systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.